How Obamacare Moved the Markets Today

It was quite the volatile day for the Dow Jones Industrial Average (INDEX: ^DJI ) , which was down big through the early afternoon today, after the Supreme Court largely upheld President Obama’s signature healthcare law. But stocks were able to stage a big rally late in the afternoon, and the Dow and S&P 500 ended up dropping just slightly on the day. The late advance was mainly due to talk of progress from the key European Summit being held today and tomorrow.

Here’s how the three major U.S. indexes fared.

Index	Change	Ending Value
Dow Jones Industrial Average	-24.75 [-0.20%]	12,602.26
Nasdaq	-25.83 [-0.90%]	2,849.49
S&P 500 (INDEX: ^GSPC )	-2.81 [-0.21%]	1,29.04

Despite their exposure to the healthcare industry, Merck, Pfizer (NYSE: PFE ) and Johnson & Johnson (NYSE: JNJ ) all ended the day essentially flat. Arena Pharmaceuticals (Nasdaq: ARNA ) , however, wasn’t quite so lucky. The stock, which gained approval yesterday for its key weight loss drug, dropped over 10% today. Some analysts expressed caution about the drug, considering previous diet drugs’ mixed history, and noted that insurers may not cover the drug until it shows more benefits than it did in trials, though sales are still are expected to be huge, given the potential demand for the pill. Check out the video below for more on what drove the markets today, and which stocks were big winners and losers.

With all the uncertainty surrounding Europe and the global economy, many investors may be tempted to take their money and run far from the market. But that can be one of the biggest mistakes investors can make. Some of the most successful stock picks are great dividend stocks purchased at attractive valuations on dips in the market. With that in mind, we've taken an in-depth look at all 30 Dow components, and picked out our three favorite Dow dividend stocks that investors can buy right now. You can find the names and analysis of these companies in our brand-new free report, "The 3 Dow Stocks Dividend Investors Need." Read the report now -- it's absolutely free.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Brendan Byrnes owns no shares of any companies mentioned. The Motley Fool owns shares of JP Morgan Chase and Johnson & Johnson. Motley Fool newsletter services have recommended buying shares of Johnson & Johnson and Pfizer. Motley Fool newsletter services have recommended creating a diagonal call position in Johnson & Johnson. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.